Indeed, blocking ox-CaMKII preserved the physiological fight/flight response whilst eliminating the increased risk of death from myocardial infarction in diabetic mice (Luo et al., 2013), highlighting the potential therapeutic benefit of blocking ox-CaMKII in a clinical setting. This evidence concerns the gene CAMK2G and myocardial infarction.